• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L4F3抗原由单能和多能集落形成细胞表达,但其前体细胞不表达。

The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors.

作者信息

Andrews R G, Takahashi M, Segal G M, Powell J S, Bernstein I D, Singer J W

出版信息

Blood. 1986 Nov;68(5):1030-5.

PMID:3768529
Abstract

Antibody L4F3 is a murine monoclonal antibody that recognizes an antigen expressed on in vitro colony-forming cells, including virtually all CFU-GM, CFU-Meg, BFU-E, and CFU-Mix. In the present study we examined whether cells that do not express the L4F3 antigen include precursors of hematopoietic colony-forming cells. Colony-forming cells were depleted from marrow by treatment with L4F3 and complement. The remaining cells generated CFU-GM, BFU-E, and CFU-Mix when cultured in the presence of irradiated adherent cell layers from long-term marrow cultures. Marrow cells not expressing the L4F3 antigen, which were separated by cell-sorting techniques, were depleted of colony-forming cells but nevertheless generated CFU-GM when cultured over irradiated adherent cell layers. These data suggest that there are marrow precursors that do not express the L4F3 antigen and that give rise to colony-forming cells of multiple types. Negative selection techniques should allow the enrichment of these precursors of colony-forming cells, thereby enabling direct studies of these immature stem cells.

摘要

抗体L4F3是一种鼠单克隆抗体,可识别在体外集落形成细胞上表达的一种抗原,这些细胞几乎包括所有的粒系巨噬系集落形成单位(CFU-GM)、巨核系集落形成单位(CFU-Meg)、爆式红系集落形成单位(BFU-E)和混合集落形成单位(CFU-Mix)。在本研究中,我们检测了不表达L4F3抗原的细胞是否包括造血集落形成细胞的前体。通过用L4F3和补体处理,从骨髓中去除集落形成细胞。当在来自长期骨髓培养的经辐照的贴壁细胞层存在的情况下培养时,剩余的细胞产生了CFU-GM、BFU-E和CFU-Mix。通过细胞分选技术分离的不表达L4F3抗原的骨髓细胞,其集落形成细胞被去除,但当在经辐照的贴壁细胞层上培养时仍产生CFU-GM。这些数据表明,存在不表达L4F3抗原但能产生多种类型集落形成细胞的骨髓前体。阴性选择技术应能使这些集落形成细胞前体得到富集,从而能够直接研究这些未成熟干细胞。

相似文献

1
The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors.L4F3抗原由单能和多能集落形成细胞表达,但其前体细胞不表达。
Blood. 1986 Nov;68(5):1030-5.
2
Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.单克隆抗体12 - 8识别一种存在于单能和多能造血集落形成细胞及其前体上的115千道尔顿分子。
Blood. 1986 Mar;67(3):842-5.
3
Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.Thy-1是一种分化抗原,可表征未成熟的小鼠红系和髓系造血祖细胞。
J Cell Physiol. 1985 Apr;123(1):25-32. doi: 10.1002/jcp.1041230105.
4
Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.用My10和主要组织相容性复合体II类单克隆抗体通过双色细胞分选高度富集的成人人类骨髓造血祖细胞的特征分析
J Immunol. 1987 Sep 15;139(6):1823-9.
5
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.单克隆抗体H25、H366和MY9与急性髓细胞白血病患者正常祖细胞和原始细胞的个体及联合反应性分析。
Leukemia. 1989 Jun;3(6):446-52.
6
Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.抗髓细胞抗体对长期骨髓培养中造血集落形成单位生成的影响。
Bone Marrow Transplant. 1989 May;4(3):309-15.
7
Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.抗CD33封闭的蓖麻毒素免疫毒素对CD34 +人骨髓细胞在长期骨髓培养中建立体外造血能力的影响。
Exp Hematol. 1992 May;20(4):442-8.
8
Identification of hematopoietic stem cell subsets on the basis of their primitiveness using antibody ER-MP12.使用抗体ER-MP12基于其原始性鉴定造血干细胞亚群。
Blood. 1995 Feb 15;85(4):952-62.
9
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.用识别髓系分化抗原的单克隆抗体在体外处理急性髓系白血病细胞可使正常祖细胞得以表达。
J Clin Invest. 1987 Apr;79(4):1153-9. doi: 10.1172/JCI112932.
10
Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen.在具有白细胞介素3受体相关抗原的造血祖细胞部分中,小鼠骨髓自然抑制活性增强。
Exp Hematol. 1992 Feb;20(2):256-63.

引用本文的文献

1
NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.非门控 CD93 CAR T 细胞可有效靶向 AML,同时最小化内皮细胞交叉反应性。
Blood Cancer Discov. 2021 Sep 16;2(6):648-665. doi: 10.1158/2643-3230.BCD-20-0208. eCollection 2021 Nov.
2
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.急性髓系白血病治疗中吉妥珠单抗奥佐米星反应的生物标志物。
Int J Mol Sci. 2020 Aug 6;21(16):5626. doi: 10.3390/ijms21165626.
3
Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
在异体干细胞移植前,急性髓系白血病微小残留病灶导向治疗最有前途的靶点有哪些?
Haematologica. 2019 Aug;104(8):1521-1531. doi: 10.3324/haematol.2018.208587.
4
Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies.结合生物学与化学,开启化疗新视角:血液系统恶性肿瘤中的抗体药物偶联物
Curr Hematol Malig Rep. 2018 Dec;13(6):555-569. doi: 10.1007/s11899-018-0485-3.
5
Clinical targeting recombinant immunotoxins for cancer therapy.用于癌症治疗的临床靶向重组免疫毒素
Onco Targets Ther. 2017 Jul 20;10:3645-3665. doi: 10.2147/OTT.S134584. eCollection 2017.
6
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia.急性髓系白血病中CD33和CD123的细胞表面表达分布及水平
Blood Cancer J. 2014 Jun 13;4(6):e218. doi: 10.1038/bcj.2014.39.
7
Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia.人类急性髓系白血病造血祖细胞中克隆扩增的异质性以及与成熟相关的突变获得情况
Leukemia. 2014 Oct;28(10):1969-77. doi: 10.1038/leu.2014.107. Epub 2014 Mar 18.
8
Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.复发难治性儿童急性髓系白血病:现有及新出现的治疗方法。
Paediatr Drugs. 2014 Apr;16(2):151-68. doi: 10.1007/s40272-013-0048-y.
9
Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.吉妥珠单抗奥佐米星治疗急性髓细胞白血病的抗体疗法。
Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1311-34. doi: 10.2741/4181.
10
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.吉妥珠单抗奥佐米星治疗急性髓细胞白血病的疗效和耐药性。
Int J Hematol. 2013 Jun;97(6):703-16. doi: 10.1007/s12185-013-1365-1. Epub 2013 May 26.